speb/financial-data huggingface dataset:
CSHR income_statement (annual, 2024-12-31) — Interest Income: 8495000.00
CSHR income_statement (quarterly, 2024-12-31) — Interest Income: 1239779.16
CSHR income_statement (annual, 2024-12-31) — Interest Income Non Operating: 8495000.00
CSHR income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 1239779.16
CSHR cash_flow (annual, 2024-12-31) — Interest Paid Cff: -179432.84
CSHR cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -10784470.79
CSHR cash_flow (quarterly, 2024-12-31) — Interest Paid Cfo: -1692410.36
CSHR cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 10971000.00
CSHR cash_flow (annual, 2024-12-31) — Interest Received Cfi: 8335028.55
CSHR cash_flow (quarterly, 2024-12-31) — Interest Received Cfi: 792532.53
CSHR balance_sheet (annual, 2024-12-31) — Inventory: 1190998000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Inventory: 1190998000.00
CSHR balance_sheet (annual, 2024-12-31) — Invested Capital: 420300000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Invested Capital: 420300000.00
CSHR cash_flow (annual, 2024-12-31) — Investing Cash Flow: 3090000.00
CSHR cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -8716816.81
CSHR balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 20338000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 20338000.00
CSHR balance_sheet (annual, 2024-12-31) — Investments And Advances: 20338000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 20338000.00
CSHR balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
CSHR balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
CSHR cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 316000.00
CSHR cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -428840.55
CSHR balance_sheet (annual, 2024-12-31) — Loans Receivable: 197300000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 197300000.00
CSHR balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2096000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 2096000.00
CSHR balance_sheet (annual, 2024-12-31) — Long Term Debt: 24657000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 24657000.00
CSHR balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 26753000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 26753000.00
CSHR cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2770000.00
CSHR cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -1990114.55
CSHR balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
CSHR balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
CSHR balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1709000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1709000.00
CSHR cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -429000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -457633.56
CSHR cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -28000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -413847.15
CSHR balance_sheet (annual, 2024-12-31) — Net Debt: 26007128.00
CSHR balance_sheet (quarterly, 2024-12-31) — Net Debt: 26007128.00
CSHR cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -21631350.77
CSHR cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -4472005.42
CSHR income_statement (annual, 2024-12-31) — Net Income: 162448000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Income: 40081437.98
CSHR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 162448000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 40081437.98
CSHR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 162448000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 40081436.73
CSHR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 162448000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 40081437.98
CSHR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 162448000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 40081437.98
CSHR cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 162448000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 65520355.37
CSHR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 162448000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 40081436.73
CSHR cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -1492000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -611693.02
CSHR income_statement (annual, 2024-12-31) — Net Interest Income: -2860000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Interest Income: -1055132.69
CSHR cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 5165000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: -81062.33
CSHR cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2770000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -1990114.55
CSHR cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2770000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -1990114.55
CSHR income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2860000.00
CSHR income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1055132.69
CSHR cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 96666413.20
CSHR cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 39386786.02
CSHR balance_sheet (annual, 2024-12-31) — Net PPE: 3173000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Net PPE: 3173000.00
CSHR cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -154000.00
CSHR cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -23931.89
CSHR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 381711000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 381711000.00
CSHR balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 1577034.95
CSHR balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 1577034.95
CSHR balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 1122249.83
CSHR balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 1122249.83
CSHR income_statement (annual, 2024-12-31) — Normalized EBITDA: -2816021000.00
CSHR income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -1480717254.76
CSHR income_statement (annual, 2024-12-31) — Normalized Income: -2814200340.94
CSHR income_statement (quarterly, 2024-12-31) — Normalized Income: -1473437016.75
CSHR cash_flow (annual, 2024-12-31) — Operating Cash Flow: 17270000.00
CSHR cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 17065272.12
CSHR cash_flow (annual, 2024-12-31) — Operating Gains Losses: -2956664000.00
CSHR cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -1979137005.74
CSHR income_statement (annual, 2024-12-31) — Operating Income: 83447000.00
CSHR income_statement (quarterly, 2024-12-31) — Operating Income: 407354787.63
CSHR income_statement (annual, 2024-12-31) — Operating Revenue: 150537000.00
CSHR income_statement (quarterly, 2024-12-31) — Operating Revenue: 31866710.58
CSHR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 66678210.00
CSHR balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 66678210.00
CSHR balance_sheet (annual, 2024-12-31) — Other Current Assets: 4482841000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 4482841000.00
CSHR balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 5149480000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 5149480000.00
CSHR balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 14958000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 14958000.00
CSHR income_statement (annual, 2024-12-31) — Other Gand A: 10341000.00
CSHR income_statement (quarterly, 2024-12-31) — Other Gand A: 11743732.98
CSHR income_statement (annual, 2024-12-31) — Other Income Expense: 82796000.00
CSHR income_statement (quarterly, 2024-12-31) — Other Income Expense: -365945702.99
CSHR balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11113000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 11113000.00
CSHR cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3918130000.00
CSHR cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 2969680842.40
CSHR balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2699000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 2699000.00
CSHR balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 993000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 993000.00
CSHR income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -2910985000.00
CSHR income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -1889087661.71
CSHR income_statement (annual, 2024-12-31) — Other Operating Expenses: -24000.00
CSHR income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -394625692.95
CSHR balance_sheet (annual, 2024-12-31) — Other Payable: 241705000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Payable: 241705000.00
CSHR balance_sheet (annual, 2024-12-31) — Other Properties: 2885000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Properties: 2885000.00
CSHR balance_sheet (annual, 2024-12-31) — Other Receivables: 6463000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Receivables: 6463000.00
CSHR balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1195389771.00
CSHR balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 1195389771.00
CSHR income_statement (annual, 2024-12-31) — Other Special Charges: -36816000.00
CSHR income_statement (quarterly, 2024-12-31) — Other Special Charges: -1522474945.73
CSHR income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CSHR income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CSHR balance_sheet (annual, 2024-12-31) — Payables: 373150000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Payables: 373150000.00
CSHR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 373150000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 373150000.00
CSHR balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1440392.75
CSHR balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1440392.75
CSHR income_statement (annual, 2024-12-31) — Pretax Income: 163383000.00
CSHR income_statement (quarterly, 2024-12-31) — Pretax Income: 40353953.20
CSHR cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 520000.00
CSHR cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 105737.42
CSHR income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 1902000.00
CSHR cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1902000.00
CSHR cash_flow (annual, 2024-12-31) — Purchase Of Business: -429000.00
CSHR cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -1492000.00
CSHR cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -611693.02
CSHR cash_flow (annual, 2024-12-31) — Purchase Of Investment: -55000.00
CSHR cash_flow (annual, 2024-12-31) — Purchase Of PPE: -229000.00
CSHR cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -98931.89
CSHR balance_sheet (annual, 2024-12-31) — Receivables: 205889000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Receivables: 205889000.00
CSHR income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 35636000.00
CSHR income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 7393882.93
CSHR income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3022000.00
CSHR income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 442851.90
CSHR cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2770000.00
CSHR cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -1990114.55
CSHR cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -344000.00
CSHR cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 14993.40
CSHR balance_sheet (annual, 2024-12-31) — Restricted Cash: 1486156432.65
CSHR balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 1486156432.65
CSHR balance_sheet (annual, 2024-12-31) — Retained Earnings: 342621000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 342621000.00
CSHR income_statement (annual, 2024-12-31) — Salaries And Wages: 12369000.00
CSHR cash_flow (annual, 2024-12-31) — Sale Of Business: 26881.23
CSHR cash_flow (quarterly, 2024-12-31) — Sale Of Business: -1752.32
CSHR cash_flow (annual, 2024-12-31) — Sale Of Intangibles: 0.00
CSHR cash_flow (annual, 2024-12-31) — Sale Of Investment: 5220000.00
CSHR cash_flow (quarterly, 2024-12-31) — Sale Of Investment: -26062.33
CSHR cash_flow (annual, 2024-12-31) — Sale Of PPE: 75000.00
CSHR income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 5471000.00
CSHR income_statement (annual, 2024-12-31) — Selling General And Administration: 28181000.00
CSHR income_statement (quarterly, 2024-12-31) — Selling General And Administration: 11743732.98
CSHR balance_sheet (annual, 2024-12-31) — Share Issued: 66678210.00
CSHR balance_sheet (quarterly, 2024-12-31) — Share Issued: 66678210.00
CSHR income_statement (annual, 2024-12-31) — Special Income Charges: 3134531000.00
CSHR income_statement (quarterly, 2024-12-31) — Special Income Charges: 1522474945.73
CSHR cash_flow (annual, 2024-12-31) — Stock Based Compensation: 12369000.00
CSHR cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 11250487.28
CSHR balance_sheet (annual, 2024-12-31) — Stockholders Equity: 395643000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 395643000.00
CSHR balance_sheet (annual, 2024-12-31) — Tangible Book Value: 381711000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 381711000.00
CSHR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 17132659.06
CSHR income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 10290516.98
CSHR income_statement (annual, 2024-12-31) — Tax Provision: 935000.00
CSHR income_statement (quarterly, 2024-12-31) — Tax Provision: 272516.47
CSHR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
CSHR income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.01
CSHR balance_sheet (annual, 2024-12-31) — Taxes Receivable: 127960.35
CSHR balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 127960.35
CSHR cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -312579.21
CSHR cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -280894.54
CSHR balance_sheet (annual, 2024-12-31) — Total Assets: 5946914000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Assets: 5946914000.00
CSHR balance_sheet (annual, 2024-12-31) — Total Capitalization: 420300000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 420300000.00
CSHR balance_sheet (annual, 2024-12-31) — Total Debt: 27648000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Debt: 27648000.00
CSHR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 395643000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 395643000.00
CSHR income_statement (annual, 2024-12-31) — Total Expenses: 68717000.00
CSHR income_statement (quarterly, 2024-12-31) — Total Expenses: -375488077.04
CSHR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5551271000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 5551271000.00
CSHR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 40142000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 40142000.00
CSHR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 27746000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 27746000.00
CSHR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 125011000.00
CSHR income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 40742072.90
CSHR balance_sheet (annual, 2024-12-31) — Total Tax Payable: 115423.80
CSHR balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 115423.80
CSHR income_statement (annual, 2024-12-31) — Total Unusual Items: 2993781000.00
CSHR income_statement (quarterly, 2024-12-31) — Total Unusual Items: 1523808971.70
CSHR income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 2993781000.00
CSHR income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1523808971.70
CSHR balance_sheet (annual, 2024-12-31) — Trading Securities: 766.67
CSHR balance_sheet (quarterly, 2024-12-31) — Trading Securities: 766.67
CSHR cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -997000.00
CSHR balance_sheet (annual, 2024-12-31) — Working Capital: 383247000.00
CSHR balance_sheet (quarterly, 2024-12-31) — Working Capital: 383247000.00
CSHR income_statement (annual, 2024-12-31) — Write Off: 74000.00
CSHR income_statement (quarterly, 2024-12-31) — Write Off: 0.00
CSHR income_statement (quarterly, 2025-03-31) — +Operating Expense: 981766019.00
CSHR income_statement (quarterly, 2025-03-31) — +Total Revenue: 29624624.00
CSHR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1664976.00
CSHR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2161867.00
CSHR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 37917399.00
CSHR income_statement (quarterly, 2025-03-31) — Amortization: 400062.00
CSHR income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 400062.00
CSHR balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 6359879.00
CSHR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 65532186.00
CSHR income_statement (quarterly, 2025-03-31) — Basic EPS: 0.36
CSHR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 24914411.00
CSHR cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -631571.00
CSHR balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3068794.00
CSHR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 41407.00
CSHR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 57052249.00
CSHR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1114154081.00
CSHR cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
CSHR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -103170338.00
CSHR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -486682.00
CSHR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 150613364.00
CSHR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1575227.00
CSHR cash_flow (quarterly, 2025-03-31) — Change In Payable: 1575227.00
CSHR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1575227.00
CSHR cash_flow (quarterly, 2025-03-31) — Change In Receivables: -4819603.00
CSHR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -3244376.00
CSHR cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -4819603.00
CSHR cash_flow (quarterly, 2025-03-31) — Changes In Cash: 46956344.00
CSHR balance_sheet (quarterly, 2025-03-31) — Common Stock: 41407.00
CSHR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 414836761.00
CSHR cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 279129.00
CSHR cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -4267044.00
CSHR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3574613.00
CSHR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 9335986.00
CSHR balance_sheet (quarterly, 2025-03-31) — Current Assets: 4661023513.00
CSHR balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 934220.00
CSHR balance_sheet (quarterly, 2025-03-31) — Current Debt: 22045933.00
CSHR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 22980153.00
CSHR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4263767520.00
CSHR cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 295033.00
CSHR cash_flow (quarterly, 2025-03-31) — Deferred Tax: 295033.00
CSHR cash_flow (quarterly, 2025-03-31) — Depreciation: -399717.00
CSHR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: -399717.00
CSHR income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 641969.00
CSHR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: -399717.00
CSHR income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 641969.00
CSHR income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 241907.00
CSHR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 71489658.00
CSHR income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.33
CSHR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 23591587.00
CSHR balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 40743.00
CSHR income_statement (quarterly, 2025-03-31) — EBIT: 25991624.00
CSHR income_statement (quarterly, 2025-03-31) — EBITDA: 26633593.00
CSHR income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
CSHR cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -14818505.00
CSHR cash_flow (quarterly, 2025-03-31) — End Cash Position: 57052249.00
CSHR balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 18965239.00
CSHR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -103170338.00
CSHR balance_sheet (quarterly, 2025-03-31) — Finished Goods: 2044836213.00
CSHR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 149981793.00
CSHR cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -12118806.00
CSHR cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 1231465204.00
CSHR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -401650610.00
CSHR income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -762.00
CSHR balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 22072098.00
CSHR income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5854324.00
CSHR balance_sheet (quarterly, 2025-03-31) — Goodwill: 2820039.00
CSHR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 14266447.00
CSHR income_statement (quarterly, 2025-03-31) — Gross Profit: 26050011.00
CSHR income_statement (quarterly, 2025-03-31) — Interest Expense: 2105004.00
CSHR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2105004.00
CSHR income_statement (quarterly, 2025-03-31) — Interest Income: 154059.00
CSHR income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 154059.00
CSHR cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -2060788.00
CSHR cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 144889.00
CSHR balance_sheet (quarterly, 2025-03-31) — Inventory: 2044836213.00
CSHR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 462215481.00
CSHR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -486682.00
CSHR balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 25325118.00
CSHR balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 25325118.00
CSHR balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 0.00
CSHR cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 279129.00
CSHR balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2134574.00
CSHR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 25332787.00
CSHR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 27467361.00
CSHR cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -58543.00
CSHR balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 0.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -3987915.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -11694038.00
CSHR income_statement (quarterly, 2025-03-31) — Net Income: 23591587.00
CSHR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 23591587.00
CSHR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 23591587.00
CSHR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 23591587.00
CSHR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 23591587.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 23591587.00
CSHR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 23591587.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -526929.00
CSHR income_statement (quarterly, 2025-03-31) — Net Interest Income: -1950945.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -307.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -307.00
CSHR income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1950945.00
CSHR cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -99123573.00
CSHR balance_sheet (quarterly, 2025-03-31) — Net PPE: 2930241.00
CSHR cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -104642.00
CSHR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 400570314.00
CSHR balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 1404283.00
CSHR income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 428285727.00
CSHR income_statement (quarterly, 2025-03-31) — Normalized Income: 420282758.17
CSHR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 150613364.00
CSHR cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1207652360.00
CSHR income_statement (quarterly, 2025-03-31) — Operating Income: -955716008.00
CSHR income_statement (quarterly, 2025-03-31) — Operating Revenue: 29565621.00
CSHR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 66330451.00
CSHR cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 92941020.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 22045933.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4229621562.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 22072098.00
CSHR income_statement (quarterly, 2025-03-31) — Other Gand A: 3138407.00
CSHR income_statement (quarterly, 2025-03-31) — Other Income Expense: 981553572.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 11446408.00
CSHR cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1215568904.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1122040.00
CSHR income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1383204944.00
CSHR income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 974476111.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Payable: 1423.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Receivables: 40743.00
CSHR balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1057101832.00
CSHR income_statement (quarterly, 2025-03-31) — Other Special Charges: 401650610.00
CSHR income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CSHR balance_sheet (quarterly, 2025-03-31) — Payables: 1829819.00
CSHR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 11165805.00
CSHR balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1971423.00
CSHR income_statement (quarterly, 2025-03-31) — Pretax Income: 23886620.00
CSHR cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 279129.00
CSHR cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -104642.00
CSHR balance_sheet (quarterly, 2025-03-31) — Receivables: 2306635.00
CSHR income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4616299.00
CSHR income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: -399717.00
CSHR cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -58543.00
CSHR cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -4267044.00
CSHR balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1404814141.00
CSHR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 354805857.00
CSHR income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2715917.00
CSHR cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CSHR income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 793615.00
CSHR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6647939.00
CSHR balance_sheet (quarterly, 2025-03-31) — Share Issued: 66330451.00
CSHR income_statement (quarterly, 2025-03-31) — Special Income Charges: -401650610.00
CSHR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 150186.00
CSHR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 414836761.00
CSHR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 400570314.00
CSHR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -4960962.83
CSHR income_statement (quarterly, 2025-03-31) — Tax Provision: 295033.00
CSHR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.01
CSHR balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 104025.00
CSHR cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -251330.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Assets: 4706071642.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 440169548.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Debt: 50447514.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 414836761.00
CSHR income_statement (quarterly, 2025-03-31) — Total Expenses: 985340632.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4291234881.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 45048129.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 27467361.00
CSHR income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 25838327.00
CSHR balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 163420.00
CSHR income_statement (quarterly, 2025-03-31) — Total Unusual Items: -401652134.00
CSHR income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -401652134.00
CSHR balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 347759.00
CSHR balance_sheet (quarterly, 2025-03-31) — Working Capital: 397255993.00
CSHR income_statement (quarterly, 2025-06-30) — +Operating Expense: -958127911.00
CSHR income_statement (quarterly, 2025-06-30) — +Total Revenue: 29988852.00
CSHR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1613551.00
CSHR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2522754.00
CSHR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 41457555.00
CSHR balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 6493668.00
CSHR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 65444951.00
CSHR income_statement (quarterly, 2025-06-30) — Basic EPS: 0.49
CSHR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 57052249.00
CSHR balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2873085.00
CSHR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 43722.00
CSHR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 73234599.00
CSHR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1473147458.00
CSHR cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -12799380.00
CSHR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 101970662.00
CSHR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -122531.00
CSHR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -66561425.00
CSHR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1209542.00
CSHR cash_flow (quarterly, 2025-06-30) — Change In Payable: 1209542.00
CSHR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1209542.00
CSHR cash_flow (quarterly, 2025-06-30) — Change In Receivables: -43119763.00
CSHR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -41910221.00
CSHR cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -43119763.00
CSHR cash_flow (quarterly, 2025-06-30) — Changes In Cash: 35286707.00
CSHR balance_sheet (quarterly, 2025-06-30) — Common Stock: 43722.00
CSHR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 410091146.00
CSHR cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -5574586.00
CSHR cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -6349606.00
CSHR income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4942056.00
CSHR balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 10018096.00
CSHR balance_sheet (quarterly, 2025-06-30) — Current Assets: 6135879700.00
CSHR balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 845806.00
CSHR balance_sheet (quarterly, 2025-06-30) — Current Debt: 41457125.00
CSHR balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 42302931.00
CSHR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5741636429.00
CSHR cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 362320.00
CSHR cash_flow (quarterly, 2025-06-30) — Deferred Tax: 362320.00
CSHR cash_flow (quarterly, 2025-06-30) — Depreciation: 1538838.00
CSHR cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1538838.00
CSHR cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1538838.00
CSHR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 65444951.00
CSHR income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.49
CSHR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 32255180.00
CSHR balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 317020.00
CSHR income_statement (quarterly, 2025-06-30) — EBIT: 33566380.00
CSHR income_statement (quarterly, 2025-06-30) — EBITDA: 35105218.00
CSHR cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -19104357.00
CSHR cash_flow (quarterly, 2025-06-30) — End Cash Position: 73234600.00
CSHR balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 19103296.00
CSHR cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 101970662.00
CSHR balance_sheet (quarterly, 2025-06-30) — Finished Goods: 2543877161.00
CSHR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -66125863.00
CSHR cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -210149506.00
CSHR cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -796299340.00
CSHR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 222077862.00
CSHR income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 50168.00
CSHR balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 368589869.00
CSHR income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 10998878.00
CSHR balance_sheet (quarterly, 2025-06-30) — Goodwill: 2820039.00
CSHR balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14902508.00
CSHR income_statement (quarterly, 2025-06-30) — Gross Profit: 25046796.00
CSHR income_statement (quarterly, 2025-06-30) — Interest Expense: 948880.00
CSHR income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 948880.00
CSHR income_statement (quarterly, 2025-06-30) — Interest Income: 322084.00
CSHR income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 322084.00
CSHR cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -905823.00
CSHR cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 313361.00
CSHR balance_sheet (quarterly, 2025-06-30) — Inventory: 2543877161.00
CSHR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 479405146.00
CSHR cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -122530.00
CSHR balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 25596964.00
CSHR balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 25597731.00
CSHR balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 767.00
CSHR cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -5574586.00
CSHR balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2027279.00
CSHR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 27856875.00
CSHR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 29884154.00
CSHR cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -405969.00
CSHR balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 767.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -11924192.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -18772656.00
CSHR income_statement (quarterly, 2025-06-30) — Net Income: 32255180.00
CSHR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 32255180.00
CSHR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 32255180.00
CSHR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 32255180.00
CSHR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 32255180.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 32255181.00
CSHR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 32255180.00
CSHR income_statement (quarterly, 2025-06-30) — Net Interest Income: -626796.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -464205.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -464205.00
CSHR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -626796.00
CSHR cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 127099896.00
CSHR balance_sheet (quarterly, 2025-06-30) — Net PPE: 2896229.00
CSHR cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -91367.00
CSHR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 395188638.00
CSHR balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 1283183.00
CSHR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -187072980.00
CSHR income_statement (quarterly, 2025-06-30) — Normalized Income: -187455029.81
CSHR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -66561425.00
CSHR cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1025221502.00
CSHR income_statement (quarterly, 2025-06-30) — Operating Income: 983174707.00
CSHR income_statement (quarterly, 2025-06-30) — Operating Revenue: 29988852.00
CSHR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 65444951.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 208337367.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 41457125.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 5559000836.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 368589869.00
CSHR income_statement (quarterly, 2025-06-30) — Other Gand A: 10998878.00
CSHR income_statement (quarterly, 2025-06-30) — Other Income Expense: -949930411.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 12082469.00
CSHR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1007000183.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1052375.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: -3.00
CSHR income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1172058441.00
CSHR income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -969126789.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Payable: 128450291.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Receivables: 317020.00
CSHR balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1399912859.00
CSHR income_statement (quarterly, 2025-06-30) — Other Special Charges: -222077862.00
CSHR income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
CSHR balance_sheet (quarterly, 2025-06-30) — Payables: 130314566.00
CSHR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 140332662.00
CSHR balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2018894.00
CSHR income_statement (quarterly, 2025-06-30) — Pretax Income: 32617500.00
CSHR cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: -5574586.00
CSHR cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -91367.00
CSHR balance_sheet (quarterly, 2025-06-30) — Receivables: 3057301.00
CSHR income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4942056.00
CSHR income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1538838.00
CSHR cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -405969.00
CSHR cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -6349606.00
CSHR balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1905441519.00
CSHR cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CSHR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 10998878.00
CSHR balance_sheet (quarterly, 2025-06-30) — Share Issued: 65444951.00
CSHR income_statement (quarterly, 2025-06-30) — Special Income Charges: 222077862.00
CSHR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 39330.00
CSHR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 410091146.00
CSHR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 395188638.00
CSHR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 2467988.19
CSHR income_statement (quarterly, 2025-06-30) — Tax Provision: 362320.00
CSHR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CSHR balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 217527.00
CSHR cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -239235.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Assets: 6181611726.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 437948021.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Debt: 72187085.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 410091146.00
CSHR income_statement (quarterly, 2025-06-30) — Total Expenses: -953185855.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5771520580.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 45732026.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 29884151.00
CSHR income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 33194128.00
CSHR balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 250724.00
CSHR income_statement (quarterly, 2025-06-30) — Total Unusual Items: 222178198.00
CSHR income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 222178198.00
CSHR balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1233259.00
CSHR balance_sheet (quarterly, 2025-06-30) — Working Capital: 394243271.00
CSHR income_statement (annual, 2025-12-31) — +Operating Expense: 28714000.00
CSHR income_statement (annual, 2025-12-31) — +Total Revenue: 163193000.00
CSHR balance_sheet (annual, 2025-12-31) — Accounts Payable: 197486000.00
CSHR balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3491000.00
CSHR balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1682000.00
CSHR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 29203000.00
CSHR balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 18850000.00
CSHR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 24915000.00
CSHR cash_flow (annual, 2025-12-31) — Capital Expenditure: -2059000.00
CSHR balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2875000.00
CSHR balance_sheet (annual, 2025-12-31) — Capital Stock: 44000.00
CSHR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 64243000.00
CSHR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 64243000.00
CSHR cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -25070000.00
CSHR balance_sheet (annual, 2025-12-31) — Cash Financial: 30422.00
CSHR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -40763000.00
CSHR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -6559000.00
CSHR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 123575000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Account Payable: 4749000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -226000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -76434000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -971063000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Payable: 74485000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 74485000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Tax Payable: -226000.00
CSHR cash_flow (annual, 2025-12-31) — Change In Working Capital: -973012000.00
CSHR cash_flow (annual, 2025-12-31) — Changes In Cash: 76253000.00
CSHR balance_sheet (annual, 2025-12-31) — Common Stock: 44000.00
CSHR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 476967000.00
CSHR cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CSHR cash_flow (annual, 2025-12-31) — Common Stock Payments: -10617000.00
CSHR income_statement (annual, 2025-12-31) — Cost Of Revenue: 39707000.00
CSHR balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 47166.00
CSHR balance_sheet (annual, 2025-12-31) — Current Assets: 5343072000.00
CSHR balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1347000.00
CSHR balance_sheet (annual, 2025-12-31) — Current Debt: 3151000.00
CSHR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4498000.00
CSHR balance_sheet (annual, 2025-12-31) — Current Liabilities: 4877798000.00
CSHR cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3143000.00
CSHR income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 3143000.00
CSHR cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3143000.00
CSHR income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 3143000.00
CSHR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 114272000.00
CSHR balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 13.00